[1]
“COMPARISON OF EFFICACY OF FIXED-DOSE ROSUVASTATIN PLUS EZETIMIBE COMBINATION THERAPY VERSUS ROSUVASTATIN MONOTHERAPY IN CORONARY ARTERY DISEASE PATIENTS”, RMSR, vol. 3, no. 7, pp. 1936–1942, Jul. 2025, Accessed: Jul. 25, 2026. [Online]. Available: https://medicalsciencereview.com/index.php/Journal/article/view/1865